Sex differences in tuberculosis incidence: a pooled analysis of 11 prospective cohort studies
Yohhei Hamada, Sujen Surenthirarajah, Rishi K Gupta, Matteo Quartagno et autres
0 citationsEClinicalMedicine
Carlos Acuña-Villaorduña
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
56Publications signalées
1490Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
Tuberculosis Research and EpidemiologyMycobacterium research and diagnosisDiagnosis and treatment of tuberculosisInfectious Diseases and TuberculosisPneumonia and Respiratory Infections
Publications récentes
Optimizing Latent Tuberculosis Treatment Strategies Among Immigrants From High-Burden Settings
A. Tabackman, Meagan Karoly, Karen R. Jacobson, Charles Robert Horsburgh et autres
0 citationsmedRxiv
Low TB1 and TB2 antigen-nil is associated with increased QuantiFERON Gold Plus reversions
A. Tabackman, Carlos Acuña-Villaorduña, Martin Canning, Meagan Karoly et autres
0 citationsThe International Journal of Tuberculosis and Lung Disease
Sex Differences in Tuberculosis Incidence: A Pooled Analysis of 11 Prospective Cohort Studies
Yohhei Hamada, Sujen Surenthirarajah, Rishi K. Gupta, Matteo Quartagno et autres
0 citationsSSRN Electronic Journal
Cost effectiveness analysis of introducing rapid, alternative methods to identify multidrug-resistant tuberculosis in middle income countries
Carlos Acuña-Villaorduña, Anna Vassall, Germán Henostroza, Carlos Seas et autres
0 citations
Rifampin versus isoniazid completion rates for TB infection
M.F. Martins, Juan Alberto Díaz Plasencia, Karen R. Jacobson, Tara C. Bouton et autres
1 citationThe International Journal of Tuberculosis and Lung Disease
P-786. Rates of Treatment Discontinuation over Time with Rifampin versus Isoniazid for Latent Tuberculosis Infection: A 6-year Experience at a Large Safety-Net Clinic
M.F. Martins, Pranay Sinha, Carlos Acuña-Villaorduña
0 citationsOpen Forum Infectious Diseases
Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline
Jussi Saukkonen, Raquel Duarte, Sonal S. Munsiff, Carla A. Winston et autres
149 citationsAmerican Journal of Respiratory and Critical Care Medicine
Effectiveness of the primary Bacillus Calmette-Guérin vaccine against the risk of Mycobacterium tuberculosis infection and tuberculosis disease: a meta-analysis of individual participant data
Puck T. Pelzer, Logan Stuck, Leonardo Martínez, Alexandra S Richards et autres
16 citationsThe Lancet Microbe
Optimal Timing to Discontinue Respiratory Isolation Among Patients With Pulmonary Tuberculosis
Carlos Acuña-Villaorduña, Edward C. Jones‐López, Grant Theron, Keertan Dheda et autres
1 citationClinical Infectious Diseases
Prevalence of non‐communicable diseases among household contacts of people with tuberculosis: A systematic review and individual participant data meta‐analysis
Yohhei Hamada, Matteo Quartagno, Farihah Malik, Keolebogile Ntshamane et autres
6 citationsTropical Medicine & International Health
1898. Optimizing selection of latent TB management strategies among immigrants from high TB burden settings to the United States
Pranay Sinha, Karen R. Jacobson, C. Robert Horsburgh, Benjamin P. Linas et autres
0 citationsOpen Forum Infectious Diseases
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.